Orexo AB (publ) (ORX.ST)
SEK 14.0
(-1.13%)
SEK 14.0
(-1.13%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 42.4 Million SEK | -43.16% |
| 2022 | 74.6 Million SEK | -19.18% |
| 2021 | 92.3 Million SEK | -14.85% |
| 2020 | 108.4 Million SEK | -17.75% |
| 2019 | 131.8 Million SEK | -24.08% |
| 2018 | 173.6 Million SEK | -30.62% |
| 2017 | 250.2 Million SEK | -27.31% |
| 2016 | 344.2 Million SEK | -13.72% |
| 2015 | 398.92 Million SEK | -16.57% |
| 2014 | 478.14 Million SEK | 24.71% |
| 2013 | 383.41 Million SEK | 1253.94% |
| 2012 | 28.31 Million SEK | 6.1% |
| 2011 | 26.68 Million SEK | 235.08% |
| 2010 | 7.96 Million SEK | -5.63% |
| 2009 | 8.44 Million SEK | -39.64% |
| 2008 | 13.98 Million SEK | 5.18% |
| 2007 | 13.29 Million SEK | 43.97% |
| 2006 | 9.23 Million SEK | 204.95% |
| 2005 | 3.02 Million SEK | 113.39% |
| 2004 | 1.41 Million SEK | 4.57% |
| 2003 | 1.35 Million SEK | -33.38% |
| 2002 | 2.03 Million SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 71.7 Million SEK | 69.1% |
| 2024 Q2 | 69.2 Million SEK | -3.49% |
| 2024 Q3 | 54.3 Million SEK | -21.53% |
| 2023 FY | 42.4 Million SEK | -43.16% |
| 2023 Q1 | 64.7 Million SEK | -13.27% |
| 2023 Q3 | 64.6 Million SEK | -3.73% |
| 2023 Q4 | 42.4 Million SEK | -34.37% |
| 2023 Q2 | 67.1 Million SEK | 3.71% |
| 2022 Q1 | 77.6 Million SEK | -15.93% |
| 2022 FY | 74.6 Million SEK | -19.18% |
| 2022 Q4 | 74.6 Million SEK | -15.9% |
| 2022 Q2 | 84.4 Million SEK | 8.76% |
| 2022 Q3 | 88.7 Million SEK | 5.09% |
| 2021 Q2 | 95.7 Million SEK | -12.04% |
| 2021 Q1 | 108.8 Million SEK | 0.37% |
| 2021 FY | 92.3 Million SEK | -14.85% |
| 2021 Q4 | 92.3 Million SEK | -1.18% |
| 2021 Q3 | 93.4 Million SEK | -2.4% |
| 2020 Q3 | 120.7 Million SEK | -4.36% |
| 2020 Q4 | 108.4 Million SEK | -10.19% |
| 2020 Q1 | 140.1 Million SEK | 6.3% |
| 2020 Q2 | 126.2 Million SEK | -9.92% |
| 2020 FY | 108.4 Million SEK | -17.75% |
| 2019 Q1 | 166.4 Million SEK | -4.15% |
| 2019 FY | 131.8 Million SEK | -24.08% |
| 2019 Q4 | 131.8 Million SEK | -3.8% |
| 2019 Q3 | 137 Million SEK | -9.03% |
| 2019 Q2 | 150.6 Million SEK | -9.5% |
| 2018 Q3 | 180.5 Million SEK | -7.05% |
| 2018 Q1 | 206.1 Million SEK | -17.63% |
| 2018 Q2 | 194.2 Million SEK | -5.77% |
| 2018 FY | 173.6 Million SEK | -30.62% |
| 2018 Q4 | 173.6 Million SEK | -3.82% |
| 2017 Q4 | 250.2 Million SEK | -8.05% |
| 2017 Q3 | 272.1 Million SEK | -7.1% |
| 2017 Q2 | 292.9 Million SEK | -7.54% |
| 2017 FY | 250.2 Million SEK | -27.31% |
| 2017 Q1 | 316.8 Million SEK | -7.96% |
| 2016 FY | 344.2 Million SEK | -13.72% |
| 2016 Q4 | 344.2 Million SEK | -4.6% |
| 2016 Q3 | 360.8 Million SEK | -4.93% |
| 2016 Q2 | 379.5 Million SEK | -0.78% |
| 2016 Q1 | 382.5 Million SEK | -4.12% |
| 2015 Q4 | 398.92 Million SEK | -7.23% |
| 2015 Q2 | 447.8 Million SEK | -6.73% |
| 2015 Q1 | 480.1 Million SEK | 0.41% |
| 2015 FY | 398.92 Million SEK | -16.57% |
| 2015 Q3 | 430 Million SEK | -3.97% |
| 2014 Q2 | 435.1 Million SEK | 10.66% |
| 2014 Q1 | 393.2 Million SEK | 2.55% |
| 2014 Q3 | 473.5 Million SEK | 8.83% |
| 2014 Q4 | 478.14 Million SEK | 0.98% |
| 2014 FY | 478.14 Million SEK | 24.71% |
| 2013 Q2 | 116.1 Million SEK | 179.09% |
| 2013 FY | 383.41 Million SEK | 1253.94% |
| 2013 Q4 | 383.41 Million SEK | 67.43% |
| 2013 Q3 | 229 Million SEK | 97.24% |
| 2013 Q1 | 41.6 Million SEK | 46.9% |
| 2012 Q4 | 28.31 Million SEK | 5.27% |
| 2012 Q3 | 26.9 Million SEK | 4.67% |
| 2012 FY | 28.31 Million SEK | 6.1% |
| 2012 Q1 | 30.2 Million SEK | 13.16% |
| 2012 Q2 | 25.7 Million SEK | -14.9% |
| 2011 FY | 26.68 Million SEK | 235.08% |
| 2011 Q4 | 26.68 Million SEK | 45.69% |
| 2011 Q3 | 18.31 Million SEK | 54.4% |
| 2011 Q2 | 11.86 Million SEK | -4.38% |
| 2011 Q1 | 12.4 Million SEK | 55.79% |
| 2010 Q3 | 9.57 Million SEK | 27.24% |
| 2010 Q4 | 7.96 Million SEK | -16.83% |
| 2010 FY | 7.96 Million SEK | -5.63% |
| 2010 Q1 | 8.78 Million SEK | 4.04% |
| 2010 Q2 | 7.52 Million SEK | -14.28% |
| 2009 FY | 8.44 Million SEK | -39.64% |
| 2009 Q3 | 9.17 Million SEK | 0.0% |
| 2009 Q4 | 8.44 Million SEK | -7.98% |
| 2008 Q4 | 13.98 Million SEK | 0.0% |
| 2008 FY | 13.98 Million SEK | 5.18% |
| 2007 FY | 13.29 Million SEK | 43.97% |
| 2006 FY | 9.23 Million SEK | 204.95% |
| 2005 FY | 3.02 Million SEK | 113.39% |
| 2004 FY | 1.41 Million SEK | 4.57% |
| 2003 FY | 1.35 Million SEK | -33.38% |
| 2002 FY | 2.03 Million SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AcuCort AB | -1.09 Million SEK | 3958.053% |
| AlzeCure Pharma AB (publ) | -2508.00 SEK | 1690690.112% |
| BioGaia AB (publ) | 181.2 Million SEK | 76.601% |
| Enzymatica AB (publ) | 11.49 Million SEK | -268.728% |
| Enorama Pharma AB (publ) | 4.29 Million SEK | -887.884% |
| Gabather AB (publ) | -1772.00 SEK | 2392876.524% |
| Klaria Pharma Holding AB (publ.) | - SEK | -Infinity% |
| Moberg Pharma AB (publ) | 7.11 Million SEK | -495.924% |
| Nanexa AB (publ) | 1.91 Million SEK | -2118.734% |
| Newbury Pharmaceuticals AB (publ) | 4.99 Million SEK | -748.849% |
| ODI Pharma AB | - SEK | -Infinity% |
| Probi AB (publ) | 116.7 Million SEK | 63.669% |
| Swedencare AB (publ) | 398.1 Million SEK | 89.349% |
| Swedish Orphan Biovitrum AB (publ) | 3.87 Billion SEK | 98.906% |
| Toleranzia AB | -1.34 Million SEK | 3264.179% |
| Vivesto AB | - SEK | -Infinity% |